AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22575624 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel‐eluting stent (PES)
Number of subjects: 112
Study 22575624 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SES and PES
Number of subjects: 112
Study 21987195 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow TUG test performance (>10.2 seconds) with normal hip BMD
Number of subjects: 1126
Study 21987195 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow TUG test performance with low hip BMD
Number of subjects: 1126
Study 21987195 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal TUG test performance with low hip BMD
Number of subjects: 1126
Study 21987195 — intervention group
Group type: EXPERIMENTAL
Intervention: Both slow TUG test performance and low hip BMD
Number of subjects: 1126
Study 21987195 — intervention group
Group type: COMPARATOR
Intervention: Normal TUG test performance and normal BMD
Number of subjects: 1126
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of uterine volumes
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of dominant fibroid volumes
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of number of fibroids
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI assessment of T(1) and T(2) weighted signal intensity of dominant fibroid
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver agreement for observer A
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver agreement for observer B
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver agreement for presence of adenomyosis
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver agreement for observer A regarding adenomyosis
Number of subjects: 40
Study 18057985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraobserver agreement for observer B regarding adenomyosis
Number of subjects: 40
Study 17712019 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analyses including observational studies
Number of subjects: 0
Study 17712019 — intervention group
Group type: COMPARATOR
Intervention: Meta-analyses based on randomized controlled trials
Number of subjects: 0
Study 15138363 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin and 5-fluorouracil (PF)
Number of subjects: 94
Study 15138363 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF)
Number of subjects: 94
Study 11718446 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intervention including feedback on practice and a seminar led by specialists
Number of subjects: 112
Study 11718446 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 112
Study 9144352 — intervention group
Group type: EXPERIMENTAL
Intervention: Synovial fluid from OA patients
Number of subjects: 49
Study 9144352 — intervention group
Group type: EXPERIMENTAL
Intervention: Synovial fluid from RA patients
Number of subjects: 49
Study 9144352 — intervention group
Group type: EXPERIMENTAL
Intervention: Synovial fluid activity
Number of subjects: 49
Study 9144352 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical analysis of RA synovium
Number of subjects: 49
Study 7964484 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell lines from treatment-responsive Lyme arthritis
Number of subjects: 9
Study 7964484 — intervention group
Group type: EXPERIMENTAL
Intervention: T cell lines from treatment-resistant Lyme arthritis
Number of subjects: 9
Study 7964484 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment-responsive)
Number of subjects: 9
Study 2826549 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 24
Study 2826549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 24
Study 2826549 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Lisinopril and HCTZ
Number of subjects: 24
Study 29308709 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT) <5-minute session
Number of subjects: 10
Study 29308709 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT) 15-minute session
Number of subjects: 10
Study 26659583 — intervention group
Group type: EXPERIMENTAL
Intervention: HU + imatinib (HU 500 mg BID + imatinib 400 mg QD)
Number of subjects: 15
Study 26659583 — intervention group
Group type: COMPARATOR
Intervention: HU alone (HU 500 mg BID)
Number of subjects: 15
Study 26659583 — intervention group
Group type: EXPERIMENTAL
Intervention: HU + imatinib
Number of subjects: 15
Study 26659583 — intervention group
Group type: COMPARATOR
Intervention: HU alone
Number of subjects: 15
Study 25913166 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 100
Study 25913166 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 100
Study 23398960 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral interferon alpha
Number of subjects: 200
Study 23398960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 20626664 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 440
Study 20626664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study 18069726 — intervention group
Group type: EXPERIMENTAL
Intervention: Misspecified random-effects distribution in GLMMs
Number of subjects: 0
Study 18069726 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analysis considering several random-effects distributions
Number of subjects: 0
Study 16848808 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nitroglycerin ointment 0.2% b.i.d. for 2 weeks
Number of subjects: 50
Study 16848808 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin A injection (30 IU Botox)
Number of subjects: 50
Study 16848808 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of botulinum toxin and nitroglycerin
Number of subjects: 50
Study 16848808 — intervention group
Group type: COMPARATOR
Intervention: Topical nitroglycerin ointment
Number of subjects: 50
Study 12648882 — intervention group
Group type: EXPERIMENTAL
Intervention: Levormeloxifene
Number of subjects: 234
Study 12648882 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of levormeloxifene treatment
Number of subjects: 234
Study 10951830 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil COER-24 180/240 mg (single daily dose at bedtime)
Number of subjects: 81
Study 8981340 — intervention group
Group type: EXPERIMENTAL
Intervention: New matrix patch for estradiol delivery (active patch)
Number of subjects: 20
Study 8981340 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch (control)
Number of subjects: 20
Study 1442910 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 170
Study 1442910 — intervention group
Group type: COMPARATOR
Intervention: Standard obstetric care without amnioinfusion
Number of subjects: 170
Study 3838924 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of 0.5% bupivacaine hydrochloride (B10 group)
Number of subjects: 14
Study 3838924 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml of 0.5% bupivacaine hydrochloride (B15 group)
Number of subjects: 14
Study 3838924 — intervention group
Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 14
Study 3838924 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (B10, B15, and control) at 3-4 days post-operative
Number of subjects: 14
Study 3838924 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (B10, B15, and control) at 10-15 days post-operative
Number of subjects: 14
Study 31745072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose eicosapentaenoic acid (EPA, 1.2g)
Number of subjects: 92
Study 31745072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 30170170 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia (H)
Number of subjects: 40
Study 30170170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise under Hypoxia (EH)
Number of subjects: 40
Study 30170170 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (N)
Number of subjects: 40
Study 30170170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise under Normoxia (EN)
Number of subjects: 40
Study 27094054 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D 0° HD endoscope
Number of subjects: 46
Study 27094054 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D 0° SD endoscope
Number of subjects: 46
Study 27094054 — intervention group
Group type: COMPARATOR
Intervention: 2D 0° HD endoscope
Number of subjects: 46
Study 24621587 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care and gum chewing (n = 13)
Number of subjects: 47
Study 24621587 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care (n = 18)
Number of subjects: 47
Study 24621587 — intervention group
Group type: COMPARATOR
Intervention: Standard care and a silicone‐adhesive patch (attention control) (n = 16)
Number of subjects: 47
Study 22964160 — intervention group
Group type: EXPERIMENTAL
Intervention: T3 (25 μg/day in week 1 and increasing to 50 μg/day in week 2) plus sertraline
Number of subjects: 153
Study 22964160 — intervention group
Group type: COMPARATOR
Intervention: Sertraline plus placebo
Number of subjects: 153
Study 20543729 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine loading (20 packets of 5 g Cr citrate, 18 g dextrose)
Number of subjects: 50
Study 20543729 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 packets of 18 g dextrose)
Number of subjects: 50
Study 18035158 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination reminders to parents during hospitalization
Number of subjects: 100
Study 18035158 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 16272184 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (1.5mg/kg)
Number of subjects: 60
Study 16272184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11891025 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic nodal dissection (SND)
Number of subjects: 532
Study 11891025 — intervention group
Group type: COMPARATOR
Intervention: Mediastinal lymph nodal sampling (MLS)
Number of subjects: 532
Study 10073514 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron cooking pots
Number of subjects: 407
Study 10073514 — intervention group
Group type: COMPARATOR
Intervention: Aluminium cooking pots
Number of subjects: 407
Study 8847044 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy alone
Number of subjects: 30
Study 8847044 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy with G-CSF
Number of subjects: 30
Study 8847044 — intervention group
Group type: COMPARATOR
Intervention: G-CSF therapy
Number of subjects: 30
Study 2202706 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propranolol (administered to 15 patients, dosage adjusted to reduce resting heart rate by approximately 25%)
Number of subjects: 30
Study 2202706 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched group of 15 control subjects)
Number of subjects: 30
Study 6896965 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural administration of morphine 2 mg
Number of subjects: 0
Study 6896965 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal application of morphine
Number of subjects: 0
Study 6896965 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural or intrathecal opiate
Number of subjects: 0
Study 31829095 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of autologous bone marrow mesenchymal stem cells (MSCINJ) with intensive atorvastatin (80 mg/d)
Number of subjects: 100
Study 31829095 — intervention group
Group type: COMPARATOR
Intervention: Routine atorvastatin (20 mg/d) with placebo
Number of subjects: 100
Study 31829095 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary infusion of autologous bone marrow mesenchymal stem cells (MSCINJ) with placebo
Number of subjects: 100
Study 31829095 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine atorvastatin (20 mg/d) with MSCINJ
Number of subjects: 100
Study 30175557 — intervention group
Group type: EXPERIMENTAL
Intervention: High CHO (HCHO: 415 g) during recovery and moderate-intensity exercise (120SS)
Number of subjects: 28
Study 30175557 — intervention group
Group type: COMPARATOR
Intervention: Low CHO (LCHO: 80 g) during recovery and moderate-intensity exercise (120SS)
Number of subjects: 28
Study 30175557 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (HCHO and LCHO) after 120SS
Number of subjects: 28
Study 27333959 — intervention group
Group type: EXPERIMENTAL
Intervention: Canned tangerines (234-304g)
Number of subjects: 19
Study 27333959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink grapefruit (60-540g)
Number of subjects: 19
Study 27333959 — intervention group
Group type: EXPERIMENTAL
Intervention: Canned tangerines (234g)
Number of subjects: 19
Study 27333959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink grapefruit (540g)
Number of subjects: 19
Study 27333959 — intervention group
Group type: COMPARATOR
Intervention: Canned tangerines (234-304g) or Pink grapefruit (60-540g)
Number of subjects: 19
Study 27333959 — intervention group
Group type: COMPARATOR
Intervention: Canned tangerines (234g) or Pink grapefruit (540g)
Number of subjects: 19
Study 24510942 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-month educational intervention
Number of subjects: 58
Study 24510942 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 58
Study 20662675 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltrations of 1 mL articaine HCl 4% with epinephrine 1/200,000 to the ipsilateral mylohyoid and buccal nerves
Number of subjects: 14
Study 20662675 — intervention group
Group type: COMPARATOR
Intervention: Inferior alveolar and buccal nerve blocks
Number of subjects: 14
Study 19427768 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (mean HbA1c reduction of 0.9%)
Number of subjects: 32629
Study 17228043 — intervention group
Group type: EXPERIMENTAL
Intervention: VTrim (therapist-led structured behavioral weight loss program)
Number of subjects: 124
Study 17228043 — intervention group
Group type: COMPARATOR
Intervention: eDiets.com (self-help commercial online weight loss program)
Number of subjects: 124
Study 14635010 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha 2b 3 MU/day for 24 weeks, followed by 3 MU x 3/week for 24 weeks plus ribavirin 1-1.2 g/day for 48 weeks
Number of subjects: 106
Study 11859274 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training (12-week ergocycle program at 60% VO2 peak, one hour thrice a week)
Number of subjects: 13
Study 11859274 — intervention group
Group type: COMPARATOR
Intervention: Control group (obese subjects)
Number of subjects: 13
Study 10462926 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program at 50% of peak oxygen uptake for eight weeks
Number of subjects: 22
Study 10462926 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exercised)
Number of subjects: 22
Study 10462926 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program
Number of subjects: 22
Study 7608347 — intervention group
Group type: EXPERIMENTAL
Intervention: Group interpersonal therapy (IPT) for 12 weeks
Number of subjects: 0
Study 7608347 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group (waiting-list)
Number of subjects: 0
Study 7608347 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for 12 weeks
Number of subjects: 0
Study 2678309 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + hydrochlorothiazide 15 mg/die
Number of subjects: 0
Study 2678309 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg/die
Number of subjects: 0
Study 778518 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovar (droperidol 5 mg, fentanyl 0.1 mg)
Number of subjects: 32
Study 778518 — intervention group
Group type: EXPERIMENTAL
Intervention: Inapsine
Number of subjects: 32
Study 778518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31081281 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutured management (TEM-S)
Number of subjects: 50
Study 31081281 — intervention group
Group type: COMPARATOR
Intervention: Open management (TEM-O)
Number of subjects: 50
Study 28251399 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 39
Study 28251399 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 39
Study 25257616 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy (RSWT) - four sessions, once weekly
Number of subjects: 68
Study 25257616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 23306956 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 86
Study 23306956 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted esophagectomy (LAE)
Number of subjects: 86
Study 23306956 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OE)
Number of subjects: 86
Study 21548932 — intervention group
Group type: EXPERIMENTAL
Intervention: Data quality review process
Number of subjects: 1595
Study 21548932 — intervention group
Group type: COMPARATOR
Intervention: Countries with ≤ 25 recruited subjects
Number of subjects: 1595
Study 21548932 — intervention group
Group type: EXPERIMENTAL
Intervention: Countries with low recruiting and high recruiting
Number of subjects: 1595
Study 18163165 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX plus FA (20 mg/week) for 16 weeks
Number of subjects: 20
Study 18163165 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy for 16 weeks
Number of subjects: 20
Study 18163165 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX plus FA (20 mg/week)
Number of subjects: 20
Study 18163165 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 20
Study 16864756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 1 (high carbohydrate, high GI)
Number of subjects: 129
Study 16864756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 2 (high carbohydrate, low GI)
Number of subjects: 129
Study 16864756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 3 (high protein, high GI)
Number of subjects: 129
Study 16864756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 4 (high protein, low GI)
Number of subjects: 129
Study 12869379 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week oral treatment with 3 x 5 mg/day terbutaline
Number of subjects: 16
Study 12869379 — intervention group
Group type: COMPARATOR
Intervention: Control group (homozygous wild-type beta2ARs)
Number of subjects: 16
Study 11533316 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (enteral or parenteral)
Number of subjects: 0
Study 11533316 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9744273 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation to a rightward optical deviation
Number of subjects: 0
Study 8040808 — intervention group
Group type: EXPERIMENTAL
Intervention: Test socks (21% stretch nylon and 80% synthetic hollow‐core fiber)
Number of subjects: 21
Study 8040808 — intervention group
Group type: COMPARATOR
Intervention: Control socks (cotton or cotton/acrylic)
Number of subjects: 21
Study 2647043 — intervention group
Group type: EXPERIMENTAL
Intervention: ethamsylate
Number of subjects: 19
Study 2647043 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study 1195163 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mastectomy
Number of subjects: 0
Study 1195163 — intervention group
Group type: COMPARATOR
Intervention: Simple mastectomy with radical radiotherapy
Number of subjects: 0
Study 1195163 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment options
Number of subjects: 0
Study 30990245 — intervention group
Group type: EXPERIMENTAL
Intervention: BuMA SES
Number of subjects: 2348
Study 30990245 — intervention group
Group type: COMPARATOR
Intervention: Excel SES
Number of subjects: 2348
Study 30700375 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group using a website with goal-setting strategy and storytelling schema
Number of subjects: 524
Study 30700375 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge-only group with access to the website
Number of subjects: 524
Study 30700375 — intervention group
Group type: COMPARATOR
Intervention: Control group with only lectures and no website access
Number of subjects: 524
Study 30700375 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group
Number of subjects: 524
Study 30700375 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention overall
Number of subjects: 524
Study 28399638 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFields plus chemotherapy
Number of subjects: 204
Study 28399638 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 204
Study 25605698 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX-INF (local infiltration of dexamethasone 0.5 mg/kg)
Number of subjects: 240
Study 25605698 — intervention group
Group type: COMPARATOR
Intervention: DEX-IV (intravenous injection of dexamethasone 0.5 mg/kg, maximum dose 24 mg)
Number of subjects: 240
Study 25605698 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX-INF
Number of subjects: 240
Study 25605698 — intervention group
Group type: COMPARATOR
Intervention: DEX-IV
Number of subjects: 240
Study 23031323 — intervention group
Group type: EXPERIMENTAL
Intervention: Purebred rabbits at 30°C
Number of subjects: 96
Study 23031323 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossbred rabbits at 30°C
Number of subjects: 96
Study 23031323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient temperature increase
Number of subjects: 96
Study 23031323 — intervention group
Group type: EXPERIMENTAL
Intervention: Purebred rabbits
Number of subjects: 96
Study 23031323 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress
Number of subjects: 96
Study 21519586 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosa damascena mouthwash
Number of subjects: 50